Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-015334

Chief Financial Officer sold 7,000 shares at an average $27.44 ($192,073)

  • Chief Financial Officer gave up 14,343 shares (to pay taxes)
  • Chief Financial Officer acquired 27,946 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stokes Frank Chief Financial Officer 2026-03-03 Sale 10b5-1 −5,300 $27.32 $144,796 54,183 D
Stokes Frank Chief Financial Officer 2026-03-03 Sale 10b5-1 −1,700 $27.81 $47,277 52,483 D
Stokes Frank Chief Financial Officer 2026-03-03 Shares withheld for taxes 10b5-1 −3,611 $27.57 $99,555 48,872 D
Stokes Frank Chief Financial Officer 2026-03-04 Option exercise 10b5-1 +24,146 73,018 D
Stokes Frank Chief Financial Officer 2026-03-04 Shares withheld for taxes 10b5-1 −10,732 $28.17 $302,320 62,286 D
Stokes Frank Chief Financial Officer 2026-03-04 Option exercise 10b5-1 +3,800 $3.38 $12,844 66,086 D
Derivatives
Stokes Frank Chief Financial Officer 2026-03-03 Grant or award · Restricted Stock Units 10b5-1 +48,367 48,367 D
Stokes Frank Chief Financial Officer 2026-03-04 Option exercise · Restricted Stock Units 10b5-1 −12,186 24,372 D
Stokes Frank Chief Financial Officer 2026-03-04 Option exercise · Restricted Stock Units 10b5-1 −11,960 35,878 D
Stokes Frank Chief Financial Officer 2026-03-04 Option exercise · Stock option (right to buy) 10b5-1 −3,800 14,912 D
Open-market sales · 7,000 sh · avg $27.44 · $192,073
Loading xslF345X05/wk-form4_1772748515.xml…